oxybutynin has been researched along with Infections, Respiratory Syncytial Virus in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hervé, PL | 1 |
| Descamps, D | 1 |
| Deloizy, C | 1 |
| Dhelft, V | 1 |
| Laubreton, D | 1 |
| Bouguyon, E | 1 |
| Boukadiri, A | 1 |
| Dubuquoy, C | 1 |
| Larcher, T | 1 |
| Benhamou, PH | 1 |
| Eléouët, JF | 1 |
| Bertho, N | 1 |
| Mondoulet, L | 1 |
| Riffault, S | 1 |
1 other study available for oxybutynin and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.
Topics: Administration, Cutaneous; Animals; Female; Langerhans Cells; Mice; Respiratory Syncytial Virus Infe | 2016 |